Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35037
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hawley C. | en |
dc.contributor.author | Pascoe E.M. | en |
dc.contributor.author | See Y.P. | en |
dc.contributor.author | Viecelli A. | en |
dc.contributor.author | Voss D. | en |
dc.contributor.author | Mori T. | en |
dc.contributor.author | Kerr P. | en |
dc.contributor.author | Paul-Brent P.-A. | en |
dc.contributor.author | Cho Y. | en |
dc.contributor.author | Johnson D.W. | en |
dc.date.accessioned | 2021-05-14T11:49:44Z | en |
dc.date.available | 2021-05-14T11:49:44Z | en |
dc.date.copyright | 2020 | en |
dc.date.created | 20201120 | en |
dc.date.issued | 2020-11-20 | en |
dc.identifier.citation | Nephrology Dialysis Transplantation. Conference: 57th Annual Congress of the European Renal Association-European Dialysis and Transplant Association, ERA-EDTA 2020. Milan Italy. 35 (SUPPL 3) (pp iii225), 2020. Date of Publication: June 2020. | en |
dc.identifier.issn | 1460-2385 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/35037 | en |
dc.description.abstract | Background and Aims: An autologous arteriovenous fistula (AVF) is the preferred haemodialysis vascular access but successful creation is hampered by high rates of AVF failure. This study aimed to evaluate patient and surgical factors associated with AVF failure to improve vascular access selection and outcomes. Method(s): This is a post-hoc analysis of all participants of FAVOURED, a multi-centre, double-blind, multinational, randomized placebo-controlled trial evaluating the effect of fish oil and/or aspirin in preventing AVF failure in patients receiving haemodialysis. The primary outcome of AVF failure was a composite of fistula thrombosis and/or abandonment and/or cannulation failure at 12 months post AVF creation and secondary outcomes included individual outcome components. Patient data (demographics, comorbidities, medications and laboratory data) and surgical factors (surgical expertise, anaesthetic, intraoperative heparin use) were examined using multivariable logistic regression analyses to evaluate associations with AVF failure. Result(s): Of 536 participants, 253 patients (47%) experienced AVF failure during the study period. The mean age was 55+/-14.4 years, 64% were male, 45% were diabetic and 4% had peripheral vascular disease. Factors associated with AVF failure included female sex (odds ratio [OR] 1.78, 95% confidence interval [CI] 1.20-2.67), lower diastolic blood pressure (DBP; OR for higher DBP 0.98, 95% CI 0.97-0.99), presence of central venous catheter (OR 1.50, 95% CI 1.02-2.20, p=0.04) and aspirin requirement (OR 1.61, 95% CI 1.01-2.57). Conclusion(s): Female sex, requirement for aspirin therapy, requiring haemodialysis via a central venous catheter and lower diastolic blood pressure were factors associated with higher odds of AVF failure. These associations have potential implications for vascular access planning and warrant further studies. | en |
dc.language | English | en |
dc.language | en | en |
dc.publisher | Oxford University Press | en |
dc.subject | prevention | en |
dc.subject | randomized controlled trial | en |
dc.subject | thrombosis | en |
dc.subject | vascular access | en |
dc.subject | acetylsalicylic acid | en |
dc.subject | fish oil | en |
dc.subject | heparin | en |
dc.subject | placebo | en |
dc.subject | major clinical study | en |
dc.subject | adult | en |
dc.subject | *arteriovenous fistula | en |
dc.subject | central venous catheter | en |
dc.subject | clinical trial | en |
dc.subject | comorbidity | en |
dc.subject | conference abstract | en |
dc.subject | controlled study | en |
dc.subject | demography | en |
dc.subject | diabetes mellitus | en |
dc.subject | diastolic blood pressure | en |
dc.subject | double blind procedure | en |
dc.subject | drug combination | en |
dc.subject | drug therapy | en |
dc.subject | female | en |
dc.subject | hemodialysis | en |
dc.subject | human | en |
dc.subject | *lack of drug effect | en |
dc.subject | male | en |
dc.subject | middle aged | en |
dc.subject | multicenter study | en |
dc.subject | patient coding | en |
dc.subject | *post hoc analysis | en |
dc.title | Predictors of arterio-venous fistula failure: A post-hoc analysis of the favoured study. | en |
dc.type | Conference Abstract | en |
dc.identifier.affiliation | Nephrology | en |
dc.type.studyortrial | Randomised controlled trial | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1093/ndt/gfaa139.P1316 | - |
local.date.conferencestart | 2020-06-06 | en |
dc.identifier.source | 633422670 | en |
dc.identifier.institution | (See) Tan Tock Seng Hospital, Renal Medicine, Singapore, Singapore (Viecelli, Paul-Brent, Cho, Johnson, Hawley, Pascoe) Princess Alexandra Hospital, Brisbane, Nephrology, Brisbane, Australia (Voss) Middlemore Renal Department, Counties-Manukau Health, Auckland, New Zealand (Mori) Medical School, University of Western Australia, Perth, Australia (Kerr) Department of Nephrology, Monash Medical Centre, Melbourne, Australia | en |
dc.description.address | Y.P. See, Tan Tock Seng Hospital, Renal Medicine, Singapore, Singapore | en |
dc.subject.keyword | female | en |
dc.subject.keyword | hemodialysis | en |
dc.subject.keyword | human | en |
dc.subject.keyword | *lack of drug effect | en |
dc.subject.keyword | major clinical study | en |
dc.subject.keyword | male | en |
dc.subject.keyword | middle aged | en |
dc.subject.keyword | multicenter study | en |
dc.subject.keyword | patient coding | en |
dc.subject.keyword | *post hoc analysis | en |
dc.subject.keyword | prevention | en |
dc.subject.keyword | comorbidity | en |
dc.subject.keyword | thrombosis | en |
dc.subject.keyword | vascular access | en |
dc.subject.keyword | clinical trial | en |
dc.subject.keyword | central venous catheter | en |
dc.subject.keyword | *arteriovenous fistula | en |
dc.subject.keyword | adult | en |
dc.subject.keyword | randomized controlled trial | en |
dc.subject.keyword | conference abstract | en |
dc.subject.keyword | controlled study | en |
dc.subject.keyword | demography | en |
dc.subject.keyword | diabetes mellitus | en |
dc.subject.keyword | diastolic blood pressure | en |
dc.subject.keyword | double blind procedure | en |
dc.subject.keyword | drug combination | en |
dc.subject.keyword | drug therapy | en |
dc.relation.libraryurl | LibKey Link | en |
dc.description.publicationstatus | CONFERENCE ABSTRACT | en |
local.date.conferenceend | 2020-06-09 | en |
dc.rights.statement | Copyright 2020 Elsevier B.V., All rights reserved. | en |
dc.identifier.affiliationext | (See) Tan Tock Seng Hospital, Renal Medicine, Singapore, Singapore | - |
dc.identifier.affiliationext | (Viecelli, Paul-Brent, Cho, Johnson, Hawley, Pascoe) Princess Alexandra Hospital, Brisbane, Nephrology, Brisbane, Australia | - |
dc.identifier.affiliationext | (Voss) Middlemore Renal Department, Counties-Manukau Health, Auckland, New Zealand | - |
dc.identifier.affiliationext | (Mori) Medical School, University of Western Australia, Perth, Australia | - |
dc.identifier.affiliationmh | (Kerr) Department of Nephrology, Monash Medical Centre, Melbourne, Australia | - |
item.openairetype | Conference Abstract | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
crisitem.author.dept | Nephrology | - |
Appears in Collections: | Conferences |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.